Fairmount Funds Management LLC 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:15 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 0 0.000% | -6,632,015 (Position Closed) | Filing |
| 2024-02-14 3:47 pm Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 6,632,015 9.900% | 1,362,728 (+25.86%) | Filing |
| 2023-02-14 3:45 pm Purchase | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 5,269,287 9.900% | 3,219,287 (+157.04%) | Filing |
| 2022-08-25 09:32 am Purchase | 2022-08-16 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 2,050,000 5.450% | 2,050,000 (New Position) | Filing |